The United Arab Emirates (UAE) is one of the most attractive growth markets globally for medical devices and Software as a Medical Device (SaMD).
Why the United Arab Emirates (UAE) is a Strong Market for MedTech & SaMD? See our previous post here about. B.c. of:
- Rapid healthcare digitization and modernization under Vision 2030
- Increasing demand for innovative medical devices, digital health, and software-based solutions
- Clear but stringent regulatory framework under the Saudi Food & Drug Authority (SFDA), favoring well-prepared entrants.
For companies that meet regulatory requirements early, Saudi Arabia can serve as a gateway to broader MENA market expansion.
Why we provide specialized, end-to-end regulatory and market access support for medical device manufacturers, IVD companies, pharmaceutical firms, and biotechnology innovators across the MENA region, with a strong focus on the UAE / Saudi Arabia. We also support companies throughout the entire regulatory life-cycle, including:
- Authorized Representative (AR) services
- Medical device and SaMD registration
- Regulatory strategy aligned with SFDA requirements
- Cross-market expansion across Egypt and the wider MENA region Our local expertise and hands-on regulatory execution ensure a compliant and efficient path to market.
The Deal Offer Book a free 1:1 consultation to explore the Saudi Arabian MedTech and SaMD market and understand the first mandatory step for market access: appointing an Authorized Representative (AR), till end of January.
Contact us here for your request. Contacts
During this session, we will:
- Assess your product category (MedTech, IVD, SaMD)
- Explain SFDA regulatory pathways and timelines =>Clarify AR requirements and responsibilities
- Outline a practical, step-by-step market entry roadmap Expected Outcome for HealthTech Companies After the consultation, you will have:
- A clear understanding of Saudi Arabia’s regulatory entry requirements
- Clarity on whether and how an Authorized Representative is required
- An initial regulatory and market access roadmap tailored to your product
- A decision-ready foundation for entering the Saudi and wider MENA market This deal is ideal for healthtech companies evaluating Saudi Arabia as their next growth market or preparing for regulatory submission.
Deal Requirements:
ISO 13485 certificate from an IAF accredited NB A technical file as per the EU MDR – the certificate itself is not mandatory; only a TD.
Driven by Vision 2030 of the UAE, sustained public healthcare investment, and a double-digit CAGR forecast through 2030, the Kingdom offers significant opportunities for Health & MedTech companies ready to enter a regulated, high-value market.
However, market entry requires a clear regulatory strategy—starting with the appointment of an Authorized Representative (AR).
Next Steps if Accepted
We will invite companies for a first set up call to discuss timing and most pressing questions.
Contact us here for your request. Contacts
See also:
Contact us here for your request. Contacts
Our team will contact you shortly to schedule your deal session.